Retraction

Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1007/s11033-016-3986-y

Citations (5)

5
Total Citations
2
Post-Retraction
(40.0%)
2
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
1 After 2+ years
1770 Days since retraction (latest)
Paper citing Fibroblast growth factor receptor 4 polymorphisms ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Fibroblast growth factor receptor 4 polymorphisms ...
Unknown Authors
Unknown Journal
Published: Apr 2021
1770 days after retraction
Paper citing Fibroblast growth factor receptor 4 polymorphisms ...
Unknown Authors
Unknown Journal
Published: Apr 2018
679 days after retraction
Paper citing Fibroblast growth factor receptor 4 polymorphisms ...
Unknown Authors
Unknown Journal
Published: Aug 2014
662 days before retraction
Transforming Growth Factor-Beta Polymorphisms and Serum Level in the Development of Osteosarcoma
Shaogang Xu, Shufeng Yang, Guojing Sun et al. (5 authors)
DNA and Cell Biology
Published: Aug 2014
53 citations
670 days before retraction
Quick Stats
Total Citations: 5
Years Since Retraction: 9.5 years
Open Access: No
Last Checked: Never
Related Papers
The role of substance P/neurokinin 1 receptor in the pathog…
Molecular Biology Reports • 51 citations
The Risk Model Based on the Three Oxidative Stress-Related …
Oxidative Medicine and Cellular Longevity • 17 citations